FORA Capital’s AbbVie ABBV Stock Holding History

FORA Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,349	Closed	-$1.24M	–	412
2025 Q3	$1.24M	Buy	+5,349	New	+$1.09M	0.22%	128
2024 Q1	–	Sell	-30,229	Closed	-$4.68M	–	390
2023 Q4	$4.68M	Buy	+30,229	New	+$4.41M	0.4%	79
2023 Q3	–	Sell	-56,652	Closed	-$7.63M	–	439
2023 Q2	$7.63M	Buy	+56,652	New	+$8.31M	1.08%	15
2023 Q1	–	Sell	-21,045	Closed	-$3.4M	–	496
2022 Q4	$3.4M	Buy	+21,045	New	+$3.23M	0.55%	45
2022 Q3	–	Sell	-3,852	Closed	-$590K	–	392
2022 Q2	$590K	Sell	3,852 -18,216	-83%	-$2.78M	0.12%	220
2022 Q1	$3.61M	Buy	22,068 +18,100	+456%	+$2.63M	0.65%	31
2021 Q4	$537K	Buy	+3,968	New	+$469K	0.21%	137
2021 Q3	–	Sell	-21,394	Closed	-$2.41M	–	336
2021 Q2	$2.41M	Buy	+21,394	New	+$2.41M	0.45%	49
2020 Q3	–	Sell	-27,314	Closed	-$2.68M	–	620
2020 Q2	$2.68M	Buy	27,314 +21,379	+360%	+$1.88M	0.92%	10
2020 Q1	$452K	Buy	+5,935	New	+$506K	0.1%	264

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

FORA Capital's ABBV Position: Q4 2025 in Review

FORA Capital sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 5,349 shares — an estimated $1.24M sold.

FORA Capital first reported a position in ABBV in Q1 2020 and held it in 10 quarters. The position peaked at $7.63M in Q2 2023. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

FORA Capital reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
FORA Capital sold 5,349 AbbVie shares in Q4 2025, an estimated $1.24M.
FORA Capital first reported a position in AbbVie in Q1 2020 and held it in 10 quarters.
FORA Capital's AbbVie position peaked at $7.63M in Q2 2023.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.